FDA Brief

Warning letters Devices

FDA warning letter to

DFI Co., Ltd.

Issued May 6, 2025Posted Jun 3, 2025Center for Devices and Radiological Health

CGMP/QSR/Medical Devices/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.

DFI Co., Ltd.'s FDA history

Recalls in the last 12 months

May 13 Class II DFI Co., Ltd.
Device
One Step K in vitro diagnostic test REF: 81A4
The devices were distributed without required FDA premarket clearance or approval.
May 13 Class II DFI Co., Ltd.
Device
Uric Acid in vitro diagnostic test REF: 31H0P
The devices were distributed without required FDA premarket clearance or approval.
May 13 Class II DFI Co., Ltd.
Device
QUCARE Total Cholesterol in vitro diagnostic test REF: 6407
The devices were distributed without required FDA premarket clearance or approval.
May 13 Class II DFI Co., Ltd.
Device
One Step P in vitro diagnostic test REF: 8194
The devices were distributed without required FDA premarket clearance or approval.
May 13 Class II DFI Co., Ltd.
Device
One Step pH in vitro diagnostic test REF: 31I4P
The devices were distributed without required FDA premarket clearance or approval.
May 13 Class II DFI Co., Ltd.
Device
One Step 10A in vitro diagnostic test
The devices were distributed without required FDA premarket clearance or approval.
May 13 Class II DFI Co., Ltd.
Device
One Step UTI in vitro diagnostic test REF: 3374
The devices were distributed without required FDA premarket clearance or approval.

Full company page